CA
AZN icon

Commerzbank Aktiengesellschaft’s AstraZeneca AZN Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-21,828
Closed -$1.66M – 875
2018
Q4 		$1.66M Hold
21,828
– – 0.02% 444
2018
Q3 		$1.73M Hold
21,828
– – 0.02% 460
2018
Q2 		$1.53M Hold
21,828
– – 0.01% 450
2018
Q1 		$1.53M Hold
21,828
– – 0.02% 461
2017
Q4 		$1.51M Hold
21,828
– – 0.02% 442
2017
Q3 		$1.48M Hold
21,828
– – 0.02% 407
2017
Q2 		$1.49M Hold
21,828
– – 0.03% 355
2017
Q1 		$1.36M Sell
21,828
-460
-2% -$26.8K 0.02% 425
2016
Q4 		$1.22M Buy
22,288
+372
+2% +$21.1K 0.02% 410
2016
Q3 		$1.44M Sell
21,916
-89
-0.4% -$5.82K 0.02% 382
2016
Q2 		$1.33M Sell
22,005
-618
-3% -$35.9K 0.01% 429
2016
Q1 		$1.27M Sell
22,623
-2,805
-11% -$169K 0.01% 447
2015
Q4 		$1.73M Sell
25,428
-56
-0.2% -$3.67K 0.01% 518
2015
Q3 		$1.62M Sell
25,484
-1,440
-5% -$94.7K 0.01% 482
2015
Q2 		$1.72M Buy
26,924
+643
+2% +$44K 0.01% 651
2015
Q1 		$1.8M Buy
26,281
+769
+3% +$53.4K 0.01% 636
2014
Q4 		$1.8M Sell
25,512
-19,916
-44% -$1.43M 0.01% 694
2014
Q3 		$3.25M Sell
45,428
-5,834
-11% -$427K 0.01% 620
2014
Q2 		$3.81M Buy
51,262
+9,329
+22% +$674K 0.02% 542
2014
Q1 		$2.72M Buy
41,933
+19,105
+84% +$1.23M 0.01% 630
2013
Q4 		$1.45M Hold
22,828
– – 0.01% 804
2013
Q3 		$1.19M Sell
22,828
-2,915
-11% -$146K 0.01% 823
2013
Q2 		$1.22M Buy
+25,743
New +$1.31M 0.01% 886

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Commerzbank Aktiengesellschaft's AZN Position: Q1 2019 in Review

Commerzbank Aktiengesellschaft sold out of AstraZeneca (AZN) in Q1 2019, closing a stake of 21,828 shares — an estimated $1.66M sold.

Commerzbank Aktiengesellschaft first reported a position in AZN in Q2 2013 and held it in 23 quarters. The position peaked at $3.81M in Q2 2014. 561 funds tracked by Wall St. Rank hold AZN as of Q1 2019.

  • Commerzbank Aktiengesellschaft reported no remaining AstraZeneca position as of Q1 2019 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 21,828 AstraZeneca shares in Q1 2019, an estimated $1.66M.
  • Commerzbank Aktiengesellschaft first reported a position in AstraZeneca in Q2 2013 and held it in 23 quarters.
  • Commerzbank Aktiengesellschaft's AstraZeneca position peaked at $3.81M in Q2 2014.
  • 561 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2019.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2019, filed 13 May 2019.